Takuya Yoshimoto

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Bayesian Predictive Probability Based on a Bivariate Index Vector for Single-Arm Phase II Study With Binary Efficacy and Safety Endpoints.

Bayesian Predictive Probability Based on a Bivariate Index Vector for Single-Arm Phase II Study With Binary Efficacy and Safety Endpoints.

Journal: Pharmaceutical statistics

Published: December 26, 2023

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes.

FGFR blockade inhibits targeted therapy-tolerant persister in basal FGFR1- and FGF2-high cancers with driver oncogenes.

Journal: NPJ precision oncology

Published: December 08, 2022

Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study.

Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study.

Journal: International journal of clinical oncology

Published: June 22, 2022

Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm.

Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm.

Journal: JCO clinical cancer informatics

Published: June 01, 2022

Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study.

Prognostic value of immune phenotype and PD-L1 status in recurrent or metastatic renal cell carcinoma: an exploratory analysis of the ARCHERY study.

Journal: Pathology

Published: February 15, 2022

Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.

Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.

Journal: International journal of clinical oncology

Published: August 27, 2021

Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free Survival.

Impact of Tumor Assessment Frequency on Statistical Power in Randomized Cancer Clinical Trials Evaluating Progression-Free Survival.

Journal: Therapeutic innovation & regulatory science

Published: March 19, 2021

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.

Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma.

Journal: International journal of clinical oncology

Published: February 04, 2021

Ecological impact evaluation by constructing in situ microcosm with porous ceramic arrowhead.

Ecological impact evaluation by constructing in situ microcosm with porous ceramic arrowhead.

Journal: Chemosphere

Published: July 31, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026